Soft tissue sarcoma is metastatic if it has spread to areas in the body away from the location of the original tumor. Soft tissue sarcoma may spread through the bloodstream or lymphatic system to ...

For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...

A doctor may use an ultrasound scan as one of the first tests to diagnose and assess a soft tissue sarcoma. An ultrasound can help doctors determine the nature of the lump and plan the most effective ...

Overall, soft tissue sarcoma has a positive 5-year survival rate. This can vary slightly according to age, sex, and treatment type. Soft tissue sarcoma is a general term used to describe cancers that ...

Angiosarcoma is an aggressive malignancy derived from endothelial cells, characterised by its rapid progression, heterogeneity and distinct clinical challenges. As a subset of soft tissue sarcomas, ...

Soft tissue sarcomas are rare - only about 13,500 cases are diagnosed in the United States each year. They arise from what are called mesenchymal cells, which form the connective tissues in the body, ...

Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...

Ravin Ratan, MD, MEd, MD Anderson, delves into how treatment paradigms and considerations differ between adult patients and pediatric patients who have soft tissue sarcomas. Ravin Ratan, MD, MEd, ...

Soft tissue sarcoma (STS) is a rare type of cancer that can quietly grow in the connective tissues of the body—such as fat, muscles, nerves, blood vessels, or beneath the skin. Although it represents ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Excisional biopsies of soft tissue sarcoma of the hand are associated with more positive margins and a ...

Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma. Noting that immunotherapy for soft tissue sarcoma (STS) has ...